Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Change in Receivables (2021 - 2025)

Historic Change in Receivables for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to -$479000.0.

  • Biote's Change in Receivables fell 15531.18% to -$479000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 31103.98%. This contributed to the annual value of $2.3 million for FY2024, which is 34891.09% up from last year.
  • Biote's Change in Receivables amounted to -$479000.0 in Q3 2025, which was down 15531.18% from $1.5 million recorded in Q2 2025.
  • Biote's 5-year Change in Receivables high stood at $1.7 million for Q3 2023, and its period low was -$3.3 million during Q4 2023.
  • Moreover, its 5-year median value for Change in Receivables was $542000.0 (2022), whereas its average is $342058.8.
  • Examining YoY changes over the last 5 years, Biote's Change in Receivables showed a top increase of 36298.7% in 2023 and a maximum decrease of 42674.05% in 2023.
  • Biote's Change in Receivables (Quarter) stood at -$671000.0 in 2021, then grew by 5.81% to -$632000.0 in 2022, then crashed by 426.74% to -$3.3 million in 2023, then surged by 91.5% to -$283000.0 in 2024, then tumbled by 69.26% to -$479000.0 in 2025.
  • Its Change in Receivables stands at -$479000.0 for Q3 2025, versus $1.5 million for Q2 2025 and $907000.0 for Q1 2025.